Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
40-Hz Auditory Steady-State Response (ASSR) as a Biomarker of Genetic Defects in the <i>SHANK3</i> Gene: A Case Report of 15-Year-Old Girl with a Rare Partial <i>SHANK3</i> Duplication
oleh: Anastasia K. Neklyudova, Galina V. Portnova, Anna B. Rebreikina, Victoria Yu Voinova, Svetlana G. Vorsanova, Ivan Y. Iourov, Olga V. Sysoeva
Format: | Article |
---|---|
Diterbitkan: | MDPI AG 2021-02-01 |
Deskripsi
<i>SHANK3</i> encodes a scaffold protein involved in postsynaptic receptor density in glutamatergic synapses, including those in the parvalbumin (PV)+ inhibitory neurons—the key players in the generation of sensory gamma oscillations, such as 40-Hz auditory steady-state response (ASSR). However, 40-Hz ASSR was not studied in relation to SHANK3 functioning. Here, we present a 15-year-old girl (SH01) with previously unreported duplication of the first seven exons of the <i>SHANK3</i> gene (22q13.33). SH01’s electroencephalogram (EEG) during 40-Hz click trains of 500 ms duration binaurally presented with inter-trial intervals of 500–800 ms were compared with those from typically developing children (<i>n</i> = 32). SH01 was diagnosed with mild mental retardation and learning disabilities (F70.88), dysgraphia, dyslexia, and smaller vocabulary than typically developing (TD) peers. Her clinical phenotype resembled the phenotype of previously described patients with 22q13.33 microduplications (≈30 reported so far). SH01 had mild autistic symptoms but below the threshold for ASD diagnosis and microcephaly. No seizures or MRI abnormalities were reported. While SH01 had relatively preserved auditory event-related potential (ERP) with slightly attenuated P1, her 40-Hz ASSR was totally absent significantly deviating from TD’s ASSR. The absence of 40-Hz ASSR in patients with microduplication, which affected the <i>SHANK3</i> gene, indicates deficient temporal resolution of the auditory system, which might underlie language problems and represent a neurophysiological biomarker of <i>SHANK3</i> abnormalities.